Post-earnings recap
Reported
Tue, Sep 3, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a loss of $1.05 per share, but there was no revenue data available. The stock reacted slightly down by 0.04%, indicating a neutral response from investors despite the lack of detailed commentary or guidance from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.05 | N/A | — |
| Revenue | N/A | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.